Summary
We have studied the effect of meprobamate on gastic secretion, giving 7 patients 600 mg. of the drug by mouth in a single dose and measuring in the following 2 hours, volume, free acidity, and total acidity of the gastric juice withdrawn by aspiration. Results obtained from the same patients after administration of a substance whose excitosecretory effect is nil, showed no difference.
In another group of 13 patients, the fractional method of gastric analysis (Katsch-Kalk) was used and repeated 2 days after every patient had been given a daily dose of 1.2 gm. of meprobamate by mouth. In this series, as in the other, no noteworthy modification in the acidity curves was observed.
Similar content being viewed by others
References
Haverback, B. J., Stevenson, T. D., Sjoerdsma, A., andTerry, L. L. Effects of reserpine and chlorpromazine on gastric secretion.Am. J. M. Sc. 230:601, 1955.
Hollister, L. E. Hematemesis and melena complicating therapy with Rauwolfia alkaloids.Arch. Int. Med. 99:218, 1957.
Hollister, L. E. Complications from the use of tranquilizing drugs.New Engl. J. Med. 257:170, 1957.
Carlo, P. E. “Chemistry and Pharmacodynamics of Meprobamate” InPsychotropic Drugs, 1957, p. 392, Darattini & Ghetti, Milan.
Berger, F. M. Meprobamate, its pharmacologic properties and clinical uses.Internat. Rec. Med. 169 (4):184, 1956.
Bodi, T., Wirts, C. W., Jr., andMenduhe, H. Effect of meprobamate on gastric secretion and motility in patients with gastrointestinal disease, and preliminary note on its clinical use in peptic ulcer.Am. J. Gastroenterol. 29 (6):643, 1958.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cintra do Prado, F., Gomes Ferraz, W., Rodrigues Lopes, E. et al. Effect of meprobamate on gastric activity. Digest Dis Sci 6, 833–840 (1961). https://doi.org/10.1007/BF02231080
Issue Date:
DOI: https://doi.org/10.1007/BF02231080